FindTrial
Sign In

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01609868
Enrollment
60
Registered
2012-06-01
Start date
2012-06-30
Completion date
2013-06-30
Last updated
2018-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Problem With Growth of an Infant

Keywords

premature infant feeding protein

Brief summary

The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.

Interventions

DIETARY_SUPPLEMENTPowder protein modular

Infants will receive powder protein modular to achieve 4 grm/kg/day

DIETARY_SUPPLEMENTLiquid protein modular

Infants will receive a commerically avaliable liquid protein modular to provide 4 grm/kg/day

Sponsors

Alegent Health Bergan Mercy Medical Center
CollaboratorUNKNOWN
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* Infants less than 2000 gms at birth, receiving maternal breast milk

Exclusion criteria

* Infants receiving formula

Design outcomes

Primary

MeasureTime frame
Growth in premature infants (percentile ranking at 36 weeks CGA)birth to 36 weeks

Secondary

MeasureTime frameDescription
GI tolerancebirth to 36 weeksabdominal distention, feeding tolerance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026